Heritage Launches Generic Compazine Injection

Heritage Launches Generic Compazine Injection
Heritage Launches Generic Compazine Injection

Heritage Pharmaceuticals announced the launch of Prochlorperazine Edisylate Injection, the generic version of GlaxoSmithKline's former brand Compazine.

RELATED: Gastrohepactic Disorders Resource Center

Prochlorperazine Edisylate is a piperazine phenothiazine indicated for the treatment of severe nausea and vomiting. Like other phenothiazines, it exerts an antiemetic effect through a depressant action on the chemoreceptor trigger zone. It also has a clinically useful antipsychotic effect.

Prochlorperazine Edisylate Injection is available as a 5mg/mL strength in 2mL vials in 10- and 25-count packages. The product is available immediately.

For more information call (866) 901-1230 or visit HeritagePharma.com

Loading links....